First Light Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

First Light Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-499,404	Closed	-$2.65M	–	75
2019 Q3	$2.65M	Sell	499,404 -224,127	-31%	-$1.49M	0.4%	43
2019 Q2	$5.57M	Buy	723,531 +1,197	+0.2%	+$18.2K	0.77%	37
2019 Q1	$14.4M	Buy	722,334 +8,543	+1%	+$149K	1.87%	23
2018 Q4	$9.42M	Buy	+713,791	New	+$14.3M	1.5%	24

Other funds holding KDNY

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Light Asset Management's KDNY Position: Q4 2019 in Review

First Light Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2019, closing a stake of 499,404 shares — an estimated $2.65M sold.

First Light Asset Management first reported a position in KDNY in Q4 2018 and held it in 4 quarters. The position peaked at $14.4M in Q1 2019. 84 funds tracked by Wall St. Rank hold KDNY as of Q4 2019.

First Light Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
First Light Asset Management sold 499,404 Chinook Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.65M.
First Light Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
First Light Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $14.4M in Q1 2019.
84 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2019.

Based on First Light Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.